The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Antigout Drug-Global Market Insights and Sales Trends 2024
Synopsis
Gout is a form of inflammatory arthritis characterized by recurrent attacks of a red, tender, hot, and swollen joint. Pain typically comes on rapidly in less than twelve hours.The joint at the base of the big toe is affected in about half of cases.It may also result in tophi, kidney stones, or urate nephropathy.
The global Antigout Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Antigout Drug in various end use industries. The expanding demands from the Acute Gout and Chronic Gout, are propelling Antigout Drug market. Febuxostat, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Benzbromarone segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antigout Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antigout Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antigout Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antigout Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antigout Drug covered in this report include Takeda, Aspen, heumann pharma, Teijin Pharma, Horizon Pharma, Novartis, WanBang, Jiangsu Hengrui Medicine and Rotamreddy, etc.
The global Antigout Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
Aspen
heumann pharma
Teijin Pharma
Horizon Pharma
Novartis
WanBang
Jiangsu Hengrui Medicine
Rotamreddy
KPC Pharmaceuticals
Global Antigout Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antigout Drug market, Segment by Type:
Febuxostat
Benzbromarone
Allopurinol
Colchicine
Global Antigout Drug market, by Application
Acute Gout
Chronic Gout
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antigout Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antigout Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Gout is a form of inflammatory arthritis characterized by recurrent attacks of a red, tender, hot, and swollen joint. Pain typically comes on rapidly in less than twelve hours.The joint at the base of the big toe is affected in about half of cases.It may also result in tophi, kidney stones, or urate nephropathy.
The global Antigout Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Antigout Drug in various end use industries. The expanding demands from the Acute Gout and Chronic Gout, are propelling Antigout Drug market. Febuxostat, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Benzbromarone segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antigout Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antigout Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antigout Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antigout Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antigout Drug covered in this report include Takeda, Aspen, heumann pharma, Teijin Pharma, Horizon Pharma, Novartis, WanBang, Jiangsu Hengrui Medicine and Rotamreddy, etc.
The global Antigout Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
Aspen
heumann pharma
Teijin Pharma
Horizon Pharma
Novartis
WanBang
Jiangsu Hengrui Medicine
Rotamreddy
KPC Pharmaceuticals
Global Antigout Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antigout Drug market, Segment by Type:
Febuxostat
Benzbromarone
Allopurinol
Colchicine
Global Antigout Drug market, by Application
Acute Gout
Chronic Gout
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antigout Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antigout Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Antigout Drug Market Overview
1.1 Antigout Drug Product Overview
1.2 Antigout Drug Market Segment by Type
1.2.1 Febuxostat
1.2.2 Benzbromarone
1.2.3 Allopurinol
1.2.4 Colchicine
1.3 Global Antigout Drug Market Size by Type
1.3.1 Global Antigout Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Antigout Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antigout Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antigout Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antigout Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antigout Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antigout Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antigout Drug Sales Breakdown by Type (2018-2023)
2 Global Antigout Drug Market Competition by Company
2.1 Global Top Players by Antigout Drug Sales (2018-2023)
2.2 Global Top Players by Antigout Drug Revenue (2018-2023)
2.3 Global Top Players by Antigout Drug Price (2018-2023)
2.4 Global Top Manufacturers Antigout Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antigout Drug Market Competitive Situation and Trends
2.5.1 Antigout Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antigout Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antigout Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Antigout Drug Market
2.8 Key Manufacturers Antigout Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antigout Drug Status and Outlook by Region
3.1 Global Antigout Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antigout Drug Historic Market Size by Region
3.2.1 Global Antigout Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Antigout Drug Sales in Value by Region (2018-2023)
3.2.3 Global Antigout Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antigout Drug Forecasted Market Size by Region
3.3.1 Global Antigout Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Antigout Drug Sales in Value by Region (2024-2029)
3.3.3 Global Antigout Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antigout Drug by Application
4.1 Antigout Drug Market Segment by Application
4.1.1 Acute Gout
4.1.2 Chronic Gout
4.2 Global Antigout Drug Market Size by Application
4.2.1 Global Antigout Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Antigout Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Antigout Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antigout Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Antigout Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Antigout Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Antigout Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Antigout Drug Sales Breakdown by Application (2018-2023)
5 North America Antigout Drug by Country
5.1 North America Antigout Drug Historic Market Size by Country
5.1.1 North America Antigout Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antigout Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Antigout Drug Sales in Value by Country (2018-2023)
5.2 North America Antigout Drug Forecasted Market Size by Country
5.2.1 North America Antigout Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Antigout Drug Sales in Value by Country (2024-2029)
6 Europe Antigout Drug by Country
6.1 Europe Antigout Drug Historic Market Size by Country
6.1.1 Europe Antigout Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antigout Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Antigout Drug Sales in Value by Country (2018-2023)
6.2 Europe Antigout Drug Forecasted Market Size by Country
6.2.1 Europe Antigout Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Antigout Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Antigout Drug by Region
7.1 Asia-Pacific Antigout Drug Historic Market Size by Region
7.1.1 Asia-Pacific Antigout Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antigout Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antigout Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antigout Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Antigout Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antigout Drug Sales in Value by Region (2024-2029)
8 Latin America Antigout Drug by Country
8.1 Latin America Antigout Drug Historic Market Size by Country
8.1.1 Latin America Antigout Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antigout Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antigout Drug Sales in Value by Country (2018-2023)
8.2 Latin America Antigout Drug Forecasted Market Size by Country
8.2.1 Latin America Antigout Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antigout Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Antigout Drug by Country
9.1 Middle East and Africa Antigout Drug Historic Market Size by Country
9.1.1 Middle East and Africa Antigout Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antigout Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antigout Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antigout Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Antigout Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antigout Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Takeda
10.1.1 Takeda Company Information
10.1.2 Takeda Introduction and Business Overview
10.1.3 Takeda Antigout Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Takeda Antigout Drug Products Offered
10.1.5 Takeda Recent Development
10.2 Aspen
10.2.1 Aspen Company Information
10.2.2 Aspen Introduction and Business Overview
10.2.3 Aspen Antigout Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Aspen Antigout Drug Products Offered
10.2.5 Aspen Recent Development
10.3 heumann pharma
10.3.1 heumann pharma Company Information
10.3.2 heumann pharma Introduction and Business Overview
10.3.3 heumann pharma Antigout Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 heumann pharma Antigout Drug Products Offered
10.3.5 heumann pharma Recent Development
10.4 Teijin Pharma
10.4.1 Teijin Pharma Company Information
10.4.2 Teijin Pharma Introduction and Business Overview
10.4.3 Teijin Pharma Antigout Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Teijin Pharma Antigout Drug Products Offered
10.4.5 Teijin Pharma Recent Development
10.5 Horizon Pharma
10.5.1 Horizon Pharma Company Information
10.5.2 Horizon Pharma Introduction and Business Overview
10.5.3 Horizon Pharma Antigout Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Horizon Pharma Antigout Drug Products Offered
10.5.5 Horizon Pharma Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Antigout Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Novartis Antigout Drug Products Offered
10.6.5 Novartis Recent Development
10.7 WanBang
10.7.1 WanBang Company Information
10.7.2 WanBang Introduction and Business Overview
10.7.3 WanBang Antigout Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 WanBang Antigout Drug Products Offered
10.7.5 WanBang Recent Development
10.8 Jiangsu Hengrui Medicine
10.8.1 Jiangsu Hengrui Medicine Company Information
10.8.2 Jiangsu Hengrui Medicine Introduction and Business Overview
10.8.3 Jiangsu Hengrui Medicine Antigout Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Jiangsu Hengrui Medicine Antigout Drug Products Offered
10.8.5 Jiangsu Hengrui Medicine Recent Development
10.9 Rotamreddy
10.9.1 Rotamreddy Company Information
10.9.2 Rotamreddy Introduction and Business Overview
10.9.3 Rotamreddy Antigout Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Rotamreddy Antigout Drug Products Offered
10.9.5 Rotamreddy Recent Development
10.10 KPC Pharmaceuticals
10.10.1 KPC Pharmaceuticals Company Information
10.10.2 KPC Pharmaceuticals Introduction and Business Overview
10.10.3 KPC Pharmaceuticals Antigout Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 KPC Pharmaceuticals Antigout Drug Products Offered
10.10.5 KPC Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antigout Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antigout Drug Industrial Chain Analysis
11.4 Antigout Drug Market Dynamics
11.4.1 Antigout Drug Industry Trends
11.4.2 Antigout Drug Market Drivers
11.4.3 Antigout Drug Market Challenges
11.4.4 Antigout Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antigout Drug Distributors
12.3 Antigout Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
